Natriuretic Peptide Testing in Clinical Medicine

被引:23
作者
Rehman, Shafiq U.
Januzzi, James L., Jr. [1 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
natriuretic peptides; heart failure; ischemia;
D O I
10.1097/CRD.0b013e3181815333
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since the discovery of atrial natriuretic factor in 1981 by de Bold et al, there has been tremendous progress in our understanding of natriuretic peptides (NPs). Recently, testing for brain-type NP (BNP) and its amino terminal cleavage equivalent (NT-proBNP) has been rapidly adopted in clinical medicine for numerous indications, including the diagnosis and exclusion of heart failure (HF). In this regard, logical application of BNP or NT-proBNP testing may not only reduce healthcare costs but also potentially reduce adverse clinical outcomes. With respect to this fact, the potential importance of the concentration of the NPs for prognosis and the response of BNP or NT-proBNP to therapeutic intervention in terms of clinical events has been demonstrated. On the basis of these observations it is reasonable to expect that concentrations of these peptides might be useful for the management of patients with HF, acting as a gauge of therapeutic accuracy and/or stability of disease. Besides HF, the prognostic utility of NPs has been explored in other settings, particularly in ischemic heart disease and those conditions that lead to right ventricular dysfunction.
引用
收藏
页码:240 / 249
页数:10
相关论文
共 124 条
[21]   The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes [J].
de Lemos, JA ;
Morrow, DA ;
Bentley, JH ;
Omland, T ;
Sabatine, MS ;
McCabe, CH ;
Hall, C ;
Cannon, CP ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (14) :1014-1021
[22]   A RAPID AND POTENT NATRIURETIC RESPONSE TO INTRAVENOUS-INJECTION OF ATRIAL MYOCARDIAL EXTRACT IN RATS [J].
DEBOLD, AJ ;
BORENSTEIN, HB ;
VERESS, AT ;
SONNENBERG, H .
LIFE SCIENCES, 1981, 28 (01) :89-94
[23]  
Del Ry S, 2001, CLIN CHEM LAB MED, V39, P446
[24]   Effects of carvedilol on left ventricular remodeling after acute myocardial infarction -: The CAPRICORN echo substudy [J].
Doughty, RN ;
Whalley, GA ;
Walsh, HA ;
Gamble, GD ;
López-Sendón, J ;
Sharpe, N .
CIRCULATION, 2004, 109 (02) :201-206
[25]  
Elin RJ, 2004, ARCH PATHOL LAB MED, V128, P697
[26]   Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure [J].
Fitzgerald, RL ;
Cremo, R ;
Gardetto, N ;
Chiu, A ;
Clopton, P ;
Bhalla, V ;
Maisel, AS .
AMERICAN HEART JOURNAL, 2005, 150 (03) :471-477
[27]   Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure [J].
Fonarow, Gregg C. ;
Peacock, William F. ;
Phillips, Christopher O. ;
Givertz, Michael M. ;
Lopatin, Margarita .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (19) :1943-1950
[28]   Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit [J].
Forfia, PR ;
Watkins, SP ;
Rame, JE ;
Stewart, KJ ;
Shapiro, EP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (10) :1667-1671
[29]   Prevention and management of chronic heart failure in management of asymptomatic patients [J].
Frigerio, M ;
Oliva, F ;
Turazza, FM ;
Bonow, RO .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (09) :4F-9F
[30]  
Fuat A, 2006, BRIT J GEN PRACT, V56, P327